Trial
NCT03367871
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
Merck Sharp & Dohme LLC
Condition
Cervical Cancer
Intervention
Pembrolizumab
Why stopped
Investigator left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-18